AzTrials
AzTrials

Psychological DistressNCT04870385

An Islamic Psychospiritual-Acceptance and Commitment-based Prevention Program for At-risk Young Adults in the COVID-19 Pandemic

A study testing 5-week prevention program in people with Psychological Distress, run by International Islamic University Malaysia at 1 site in Malaysia.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The COVID-19 pandemic has increased mental health concerns worldwide, and young adults are at higher risk of experiencing increased psychological distress due to the pandemic. University students face compounding stressors during the pandemic, such as online and remote learning, economic insecurity, and uncertain… Read more about this study

Who is it for?
Ages 18 to 29 yearsHealthy volunteers can take part
Conditions the study is for
Psychological Distress
What is being tested?
5-week prevention program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
120 participants
Where
1 siteMalaysia
Study dates
11 Apr 2021to Aug 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 29 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Undergraduate or postgraduate student enrolled in a Malaysian university
  • aged 18-29 years old
  • Obtained moderate and above levels in either one of the stress, anxiety, and depression subscales of the DASS-21 pre-intervention assessment
  • Muslim
  • Owns a gadget with Internet access
  • Can read and understand English

Who cannot join

  • Those with previous experience with a modular ACT-based treatment with Islamic elements
  • Those with past or present diagnosis of mental/neurological disorder
  • Those reporting active suicidality
  • Those involved in any other form of psychological treatment (ie. psychotherapy, pharmacotherapy)

Trial locations and contacts

1 site in 1 country.

Malaysia1 site
  • International Islamic University Malaysia

    Kuala Lumpur, Selangor, 53100

Other trials in Malaysia

About this study

Official title: An Islamic Psychospiritual-Acceptance and Commitment-based Prevention Program for At-Risk Young Adults in the COVID-19 Pandemic

The COVID-19 pandemic has increased mental health concerns worldwide, and young adults are at higher risk of experiencing increased psychological distress due to the pandemic. University students face compounding stressors during the pandemic, such as online and remote learning, economic insecurity, and uncertain career prospects. This study aims to evaluate the effectiveness of an online modular prevention program featuring integrated elements of Acceptance and Commitment Therapy (ACT) and Islamic spirituality in reducing the psychological distress and increasing the psychological flexibility, self-compassion, and resilience of Muslim university students in Malaysia.

Being tested
5-week prevention program, Control
Keywords
Acceptance and Commitment Therapy (ACT), Islamic psychospiritual intervention, Online intervention, COVID-19, Prevention program
Medical subject headings
COVID-19

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • 5-week prevention programBehavioural

    Online modular psychological prevention program featuring integrated elements of Islamic spirituality and Acceptance and Commitment Therapy (ACT).

  • ControlBehavioural

    Control group waitlisted to receive prevention program after completion of final data collection.

Study groups in NCT04870385
Study groupRoleWhat they receive
TreatmentExperimental5-week online prevention program
Receives: Behavioral: 5-week prevention program
ControlOtherWaitlist control
Receives: Behavioral: Control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in psychological distress

    Measured using the Depression, Anxiety, and Stress Scale (DASS-21; Lovibond \& Lovibond, 1995).

    Measured: Measured at pre-intervention, mid-intervention (third week of prevention program), post-intervention (up to 1-week after completion of program), and 1-month follow-up

Secondary outcomes (3)
  1. Changes in psychological flexibility

    Measured using the Acceptance and Action Questionnaire (AAQ-II; Bond et al., 2011; Hayes et al., 2004).

    Measured: Measured at pre-intervention, mid-intervention (third week of prevention program), post-intervention (up to 1-week after completion of program), and 1-month follow-up

  2. Changes in self-compassion.

    Measured through the Self-Compassion Scale (SCS; Neff 2003; Neff, 2015).

    Measured: Measured at pre-intervention, mid-intervention (third week of prevention program), post-intervention (up to 1-week after completion of program), and 1-month follow-up

  3. Changes in resilience

    Measured by the Brief Resilience Scale (BRS; Smith et al., 2008).

    Measured: Measured at pre-intervention, mid-intervention (third week of prevention program), post-intervention (up to 1-week after completion of program), and 1-month follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 May 2021
  2. Study start11 Apr 2021
  3. Primary completion25 Jun 2021
  4. Study completionAug 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
A randomised parallel interventional study model in which there will be 2 groups, an intervention group and a waitlist control group.
Masking
None (open label)
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04870385
Sponsor's protocol ID
SPI21-052-0052
Status last verified
Aug 2021
First submitted
7 Apr 2021
Last updated
31 Aug 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing 5-week prevention program in people with Psychological Distress, run by International Islamic University Malaysia at 1 site in Malaysia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 31 Aug 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Malaysia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in psychological distress (time frame: Measured at pre-intervention, mid-intervention (third week of prevention program), post-intervention (up to 1-week after completion of program), and 1-month follow-up). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Aug 2021.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT04870385 | AzTrials